Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix
Clinical trial NCT07182838 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07182838
- Sponsor
- Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-12
- Primary completion
- 2026-08-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.